Search

Author/Creator Chiu, Joanne

1. 387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies. (9th November 2020)

Authors:
Lin, Chia-Chi; Garralda, Elena; Schöffski, Patrick; Hong, David; Siu, Lillian; Martin, Miguel; Maur, Michela; Hui, Rina; Soo, Ross; Chiu, Joanne; Zhang, Tian; Ma, Brigette; Kyi, Chrisann; Tan, Daniel; Cassier, Philippe; Sarantopoulos, John; Weickhardt, Andrew; Carvajal, Rich; Spratlin, Jennifer; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors. Issue 2 (9th February 2021)

Authors:
Wong, Jeffrey Sum Lung; Kwok, Gerry Gin Wai; Tang, Vikki; Li, Bryan Cho Wing; Leung, Roland; Chiu, Joanne; Ma, Ka Wing; She, Wong Hoi; Tsang, Josephine; Lo, Chung Mau; Cheung, Tan To; Yau, Thomas
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer. Issue 9 (28th July 2020)

Authors:
Yap, Yoon‐Sim; Chiu, Joanne; Ito, Yoshinori; Ishikawa, Takashi; Aruga, Tomoyuki; Kim, Seung Jin; Toyama, Tatsuya; Saeki, Toshiaki; Saito, Mitsue; Gounaris, Ioannis; Su, Fei; Ji, Yan; Han, Yu; Gazdoiu, Mihaela; Masuda, Norikazu
Journal:
Cancer science
Issue:
Volume 111:Issue 9(2020)
Page Start:
3313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗